VExUS Score and AKI in Critically Ill Adult patients-a Prospective Observational Study.
NCT ID: NCT06889116
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2023-05-15
2024-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods:
The patients included who have AKI at admission or developed AKI during their ICU stay were included. The definition of AKI used for this study was as defined by Kidney Disease: Improving Global Outcomes (KDIGO). Point of care VExUS scans were done on each patient at inclusion (day 0), then each day for a total of 4 days (day 1, 2 and 3), till initiation of renal replacement therapy, death or discharge form the ICU. Correlation between VExUS grades and creatinine clearances was explored as the primary objective.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VEXUS and NGAL in the Diagnosis and Prognosis of Sepsis-associated Acute Kidney Injury
NCT06305403
The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06353659
Ultrasound to Evaluate Acute Kidney Injury
NCT06241417
Accuracy of Venous Excess Ultrasound Score at Hospital Admission to Predict Acute Kidney Injury
NCT07040696
The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06341062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with AKI
Patients who are admitted with the diagnosis of AKI or develop AKI during their ICU stay
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the adult ICUs of TUTH (ICU A and ICU B)
* Admitting diagnosis of AKI or who developed AKI during their ICU stay
Exclusion Criteria
* Diagnosed case of chronic kidney disease
* Diagnosed case of cirrhosis/ portal hypertension
* Arrhythmias which would interfere with the acquisition and interpretation of the Doppler waveforms
* Inferior venacava thrombus
* Poor window for assessment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tribhuvan University Teaching Hospital, Institute Of Medicine.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bipin Karki
Principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tribhuvan University Teaching Hospital
Mahārājgañj, Bagmati, Nepal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
438(6-11)E2- 079/080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.